- Representing a Fortune 100 company in obtaining an injunction and money damages under the Lanham Act as a result of a competitor’s use of false and misleading information on its website.
- Successfully negotiating a six-figure settlement on behalf of a research institution in a complex licensing dispute involving several patents that had been licensed and sublicensed to different pharmaceutical companies.
- Successfully dismissing a complaint brought by one entertainment company against a competing entertainment company alleging claims of misappropriation of confidential information, unfair competition, and tortious interference with prospective economic advantage based on the plaintiff's failure to register as an entertainment agency under the Employment and Personnel Services Act, N.J.S.A. 34:8-43 et seq. and N.J.S.A. 56:8-1; this was the first time that we are aware of that a court in New Jersey has dismissed a complaint against an entertainment agency based on its failure to register with, and obtain a license from, the New Jersey Attorney General.
- Recovering over $5 million in lost profits damages for a global specialty chemical manufacturer against another U.S. chemical manufacturing company for breach of licensing and tolling agreement.
- Successfully defending a dietary supplement company in an action brought by the FTC charging the company with failing to have competent and reliable scientific evidence substantiating claims made regarding two popular dietary supplements. The FTC sought $24 million in fines and penalties. Following a five-day trial, the district court judge rejected the government’s allegations and issued a written opinion finding in favor of the dietary supplement company.